Case 48 y.o. healthy woman Right breast mass present for 4 weeks No other known health problems Clinical breast examination: –Fullness visible in R breast.

Slides:



Advertisements
Similar presentations
Mammary ductal carcinoma
Advertisements

BREAST CANCER CASE STUDY FRAZER BELL STUDENT BMS BSc APPLIED BIOMEDICAL SCIENCE.
Challenging Cases from the USC Multidisciplinary Breast Conference
Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology, University of Washington School of Medicine.
TRAM Educational Conference September 19, 2014 Meritus Medical Center 1.
Case presentation DR.AHMED KENSARAH.
What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)
AJCC TNM Staging 7th Edition Breast Case #3
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Normal Ultrasound Protocol Breast
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Nurse Navigators and the Cancer Institute Yousuf A. Gaffar, MD Hematology / Medical Oncology The Cancer Institute University of Maryland St. Joseph Medical.
Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.
Case Study 63: Cancer of the Female Breast
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
MAMMOGRAPHY - Pt 2 EQUIPMENT LECTURE & more….. RTEC 255 Week # 3 D. CHARMAN, M.Ed.,R.T.(R,M)
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Care Plan Demo Dr Laura Esserman This work is licensed under a Creative Commons Attribution 3.0 Unported License. © 2007 Laura J Esserman.
Microwave Radiometry Microwave Radiometry. The RTM-01-RES radiometer receives and evaluates the natural electromagnetic radiation (temperature) from the.
The Breast Clinic Index case Year 2 Michaelmas term.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Stephen John Buetow Affiliation: National Capital Consortium.
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
NYU Medical Grand Rounds Clinical Vignette Denise Pate MD, PGY-2 January 27, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
TNM BLADDER CANCER STAGING Dr. Mahnaz Roayaei Radiation Oncologist Assistant Professor Isfahan University of Medical Sciences.
Lisa Mifsud. Assessment and Management of Surgical Breast Disease.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Radiotherapy Protocols Bristol protocol version 12.
A desmoid DT. April TM 29 year-old woman No past history Right parietal mass increasing in size for 5 months DT.
Breast Cancer Dr. Gehan Mohamed. Introduction Most common female cancer. The incidence of breast cancer increases with age. 80% of cases occur in post-menopausal.
Multi Disciplinary Cancer Management –Breast Cancer Dr Masalu N. MD Medical Oncologist.
Case (I) Chemosensitive group. (a) Indistinct margined, oval shaped, hyperdense mass in Rt. UIQ with clustered pleomorphic microcalcifications (b) Nearly.
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
Slide seminar 2 4th Pannonia Congress of Pathology Eszék, May 2016 Ildikó Vereczkey National Institute of Oncology Budapest.
Case Discussion. Case #1 64 year-old postmenopausal, no PMHx Routine MMG: 2cm nodule in RUQ, with microcalcifications Biopsy: IDC grade 2 with areas of.
Fig. 16. A 56-year-old woman, who was diagnosed ovarian cancer with metastatic cancer in left axilla, underwent breast MRI. (a, b) On axial T2 and T1 weighted.
Metastatic sarcoma to the nasal bone
Case 3 Jane McNicholas Consultant Oncoplastic Breast Surgeon
Melanoma Staging an update
Advanced loco regional Regional breast cancer
CA BREAST: Clinical Aspects, Investigations, Staging
Controversy of lymph node management in breast cancer in 2017
Fatal Metastatic Cutaneous Squamous Cell Carcinoma Evolving from a Localized Verrucous Epidermal Nevus Case Rep Dermatol 2013;5: DOI: /
Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation  Rodrigo Arrangoiz, Pavlos Papavasiliou, Holly Dushkin,
Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.
Fig. 2. Mammography images of post radiation sarcoma
Ductal Carcinoma (Breast Cancer)
Basile Pache, Antonia Digklia*, Nicolas Demartines, Maurice Matter.
Case scenario- Breast Lump
Case scenario- Breast Lump
Prof. Shaila Anwar Professor Obs & Gynae
Erica V. Bloomquist, MD Heather Wright, MD
Assessing neoadjuvant chemotherapy (NAC) response in patients with breast cancer using PEM and DCE-MRI: Pilot data Kirti Kulkarni MD, Daniel Appelbaum.
Fig. 1. Preoperative mammography and breast ultrasound of a 60-year-old woman. A. Mammography reveals a 0.9 cm mass (arrows) with an indistinct margin.
Beyond Mammography: New Frontiers in Breast Cancer Screening
Avoiding Pitfalls in Mammographic Interpretation
Treatment Overview: The Multidisciplinary Team
BREAST CANCER: EXPERIENCE IN UBTH
Fig. 9. A 56-year-old woman, who underwent chemotherapy due to advanced gastric cancer, complained of swelling and erythema of left breast. She underwent.
General strategies of Cancer Treatment and evaluation of Response
Fig. 5. A 62-year-old woman with mixed invasive ductal and mucinous cancer involving left breast underwent breast MRI and PET-CT. (a) On axial breast MRI,
Presentation transcript:

Case 48 y.o. healthy woman Right breast mass present for 4 weeks No other known health problems Clinical breast examination: –Fullness visible in R breast w/o skin changes –3.5cm palpable mass R upper outer quadrant –Palpable R axillary lymph node

RIGHT 9 O’CLOCK PALPABLE RIGHT LEVEL 1 AXILLA ABNORMAL LN

Imaging Results Right breast 9 o’clock –Irregular mass –Maximum dimension 52 mm Right axilla –Multiple abnormal lymph nodes

RIGHT 9 O’CLOCK US BIOPSY RIGHT 9 O’CLOCK US BIOPSY MARKER CLIP RIGHT AXILLARY LN US BIOPSY

Histopathology Results Right breast 9 o’clock –IDC –Nottingham II/III –ER+/PR+, Her2 neg by FISH –Ki67 50% Right axilla –LN with metastatic IDC

BASELINE MRI

RIGHT 9 O’CLOCK KNOWN IDC RIGHT LEVEL 1 AXILLA KNOWN METASTATIC LAN LEFT 3 O’CLOCK NMLE 23 MM MRI BX = DCIS

Staging Studies CT C/A/P: no distant metastases Bone scan: no distant metastases

Treatment Options Surgery? Radiation Oncology? Medical Oncology?

2/09 Clinical MRI3/09 MRI after 1 week sunitinib 6/09 MRI after 12 weeks sunitinib/paclitaxel 10/09 MRI after 15 weeks doxorubicin/cyclophosphamide

Thank you!